Meixing Li

2.3k total citations
44 papers, 2.1k citations indexed

About

Meixing Li is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Meixing Li has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Biomedical Engineering and 11 papers in Materials Chemistry. Recurrent topics in Meixing Li's work include Advanced biosensing and bioanalysis techniques (20 papers), Nanoplatforms for cancer theranostics (14 papers) and RNA Interference and Gene Delivery (11 papers). Meixing Li is often cited by papers focused on Advanced biosensing and bioanalysis techniques (20 papers), Nanoplatforms for cancer theranostics (14 papers) and RNA Interference and Gene Delivery (11 papers). Meixing Li collaborates with scholars based in China, Macao and Israel. Meixing Li's co-authors include Wei Zhao, Jing‐Juan Xu, Hong‐Yuan Chen, Qingming Shen, Quli Fan, Qiumei Feng, Guoqiang Feng, Weiyong Feng, Yeneng Dai and Honghai Zhao and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Meixing Li

44 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meixing Li China 24 1.2k 1.1k 699 233 215 44 2.1k
Lu Li China 31 1.0k 0.9× 1.5k 1.3× 744 1.1× 186 0.8× 433 2.0× 83 2.8k
Xiaonan Gao China 27 1.1k 0.9× 893 0.8× 1.1k 1.5× 138 0.6× 296 1.4× 85 2.5k
Zhen Zou China 29 1.1k 1.0× 1.6k 1.4× 1.2k 1.8× 102 0.4× 302 1.4× 75 2.8k
Bin Xiong China 22 715 0.6× 623 0.5× 527 0.8× 129 0.6× 219 1.0× 53 1.6k
Danqing Lu China 23 664 0.6× 1.1k 0.9× 730 1.0× 258 1.1× 512 2.4× 36 2.0k
Zhichao Dai China 27 716 0.6× 471 0.4× 1.0k 1.4× 217 0.9× 488 2.3× 57 1.9k
Jingjin Zhao China 27 1.1k 0.9× 1.4k 1.2× 1.5k 2.2× 56 0.2× 162 0.8× 95 2.7k
Chuanliu Wu China 27 413 0.3× 1.0k 0.9× 611 0.9× 129 0.6× 195 0.9× 83 1.9k
Shizhen Chen China 26 790 0.7× 473 0.4× 764 1.1× 48 0.2× 214 1.0× 97 1.8k
Mengyi Xiong China 19 626 0.5× 950 0.8× 490 0.7× 99 0.4× 273 1.3× 44 1.5k

Countries citing papers authored by Meixing Li

Since Specialization
Citations

This map shows the geographic impact of Meixing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixing Li more than expected).

Fields of papers citing papers by Meixing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixing Li. The network helps show where Meixing Li may publish in the future.

Co-authorship network of co-authors of Meixing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Meixing Li. A scholar is included among the top collaborators of Meixing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixing Li. Meixing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qi, Guoshuai Yang, Ze Tao, et al.. (2025). A versatile 980 nm excitable small molecule for short-wave infrared fluorescence imaging guided type-I photodynamic/photothermal therapy. Sensors and Actuators B Chemical. 438. 137807–137807. 1 indexed citations
2.
Li, Lei, Hui Han, Meixing Li, et al.. (2025). NIR–II DNA Nanodevice for Spatiotemporal MicroRNAs Imaging Based on “and” Logic‐Gate Strategy. Advanced Functional Materials. 35(38). 4 indexed citations
3.
Li, Meixing, et al.. (2024). ECL cytosensor for sensitive and label-free detection of circulating tumor cells based on hierarchical flower-like gold microstructures. Analytica Chimica Acta. 1303. 342505–342505. 2 indexed citations
4.
5.
Li, Lei, Yang Zhang, Meixing Li, et al.. (2024). Near-Infrared Light-Activated DNA Nanodevice for Spatiotemporal In Vivo Fluorescence Imaging of Messenger RNA. Analytical Chemistry. 97(1). 768–774. 1 indexed citations
6.
Dai, Yeneng, Xiangyu Li, Yuwen Xue, et al.. (2023). Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy. Acta Biomaterialia. 166. 496–511. 29 indexed citations
7.
Dai, Yeneng, Fan Zhang, Kai Chen, et al.. (2023). An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR‐II Fluorescence Imaging and Synergistic NIR‐II Photothermal‐Chemodynamic Therapy. Small. 19(22). e2206053–e2206053. 43 indexed citations
8.
Dai, Yeneng, Honghai Zhao, Xiangyu Li, et al.. (2021). NIR-II fluorescence imaging guided tumor-specific NIR-II photothermal therapy enhanced by starvation mediated thermal sensitization strategy. Biomaterials. 275. 120935–120935. 103 indexed citations
9.
Dai, Yeneng, Fan Zhang, Honghai Zhao, et al.. (2021). Injectable and Thermosensitive Liposomal Hydrogels for NIR-II Light-Triggered Photothermal-Chemo Therapy of Pancreatic Cancer. ACS Applied Bio Materials. 4(10). 7595–7604. 27 indexed citations
10.
Wang, Bing, Yeneng Dai, Honghai Zhao, et al.. (2020). Tumor Microenvironment-Responsive Fe(III)–Porphyrin Nanotheranostics for Tumor Imaging and Targeted Chemodynamic–Photodynamic Therapy. ACS Applied Materials & Interfaces. 12(48). 53634–53645. 97 indexed citations
11.
Wu, Kun, Honghai Zhao, Bing Wang, et al.. (2019). Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging. Theranostics. 9(25). 7697–7713. 84 indexed citations
12.
Dai, Yeneng, Kun Wu, Bing Wang, et al.. (2019). Multifunctional Thermosensitive Liposomes Based on Natural Phase-Change Material: Near-Infrared Light-Triggered Drug Release and Multimodal Imaging-Guided Cancer Combination Therapy. ACS Applied Materials & Interfaces. 11(11). 10540–10553. 169 indexed citations
13.
Feng, Qiumei, Zhenzhen Zhou, Meixing Li, et al.. (2016). DNA tetrahedral scaffolds-based platform for the construction of electrochemiluminescence biosensor. Biosensors and Bioelectronics. 90. 251–257. 66 indexed citations
14.
Li, Meixing, et al.. (2016). Selenocysteine detection and bioimaging in living cells by a colorimetric and near-infrared fluorescent turn-on probe with a large stokes shift. Biosensors and Bioelectronics. 87. 894–900. 85 indexed citations
16.
Li, Meixing, et al.. (2012). The cardiovascular effects of a chimeric opioid peptide based on morphiceptin and PFRTic-NH2. Peptides. 39. 89–94. 4 indexed citations
17.
Li, Meixing, et al.. (2012). Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide. Regulatory Peptides. 179(1-3). 23–28. 16 indexed citations
18.
Wang, Jing, et al.. (2011). Preliminary analgesic properties of deltorphin-5-methoxytryptamine chimeric opioid peptides. Peptides. 32(5). 1055–1059. 5 indexed citations
19.
Wang, Qingfei, Meixing Li, Ying Wang, et al.. (2008). RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Letters. 269(1). 127–138. 31 indexed citations
20.
Shu, Jin, Ying Wang, Shujun Wang, et al.. (2005). [Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66].. PubMed. 21(2). 233–6, 242. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026